Evidence brief · Supplement

Glucosamine for Osteoarthritis

Evidence grade C — Trial for 8–12 weeks

Overall grade
Grade C
Last revised
1
graded outcome
0
references listed

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

1 at grade C — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • OsteoarthritisEvidence grade C

    Trial for 8–12 weeks

    Unclearmixed

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Thin evidence: Osteoarthritis (grade C).

The evidence in words

The verdict

For osteoarthritis, Glucosamine earns evidence grade C (unclear effect, mixed consistency) — the evidence is limited or mixed. Trial for 8–12 weeks

How it might work

It provides cartilage-matrix substrate and may have anti-inflammatory signaling effects; the mechanism has never cleanly matched the clinical results.

How to use it

1,500 mg/day glucosamine sulfate, often with chondroitin; give it 8–12 weeks before judging.

Safety & cautions

Well tolerated; mild GI effects. Older warnings about glucose control appear overstated.

Bottom line

Worth an 8–12 week trial for knee OA at 1,500 mg glucosamine sulfate — some get real relief, many don't. The mortality association is interesting but unproven.

How it is used

As the entry records it, from the studies it summarises. Not a recommendation for you — doses that suit a trial population may not suit you.

Standard
1,500 mg/day sulfate, ± chondroitin.

Goes with

  • GlucosamineRead the full Glucosamine monographEvidence grade C

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised . A grade is this entry's reading of the evidence, not medical advice.